My NCBI | Sign In
RSS Settings
  • Search: Pierroz DD[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 26

    1.

    Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice.

    Pierroz DD, Rufo A, Bianchi EN, Glatt V, Capulli M, Rucci N, Cavat F, Rizzoli R, Teti A, Bouxsein ML, Ferrari SL.

    J Bone Miner Res. 2009 May;24(5):775-84.PMID: 19113915 [PubMed - indexed for MEDLINE]Related articles

    2.

    Mice lacking beta-adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of ovariectomy.

    Bouxsein ML, Devlin MJ, Glatt V, Dhillon H, Pierroz DD, Ferrari SL.

    Endocrinology. 2009 Jan;150(1):144-52. Epub 2008 Sep 18.PMID: 18801900 [PubMed - indexed for MEDLINE]Related articles

    3.

    Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis.

    Bonnet N, Pierroz DD, Ferrari SL.

    J Musculoskelet Neuronal Interact. 2008 Apr-Jun;8(2):94-104. Review.PMID: 18622078 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice.

    Nissen-Meyer LS, Jemtland R, Gautvik VT, Pedersen ME, Paro R, Fortunati D, Pierroz DD, Stadelmann VA, Reppe S, Reinholt FP, Del Fattore A, Rucci N, Teti A, Ferrari S, Gautvik KM.

    J Cell Sci. 2007 Aug 15;120(Pt 16):2785-95. Epub 2007 Jul 24.PMID: 17652162 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.

    Pierroz DD, Bouxsein ML, Rizzoli R, Ferrari SL.

    Bone. 2006 Aug;39(2):260-7. Epub 2006 Mar 10.PMID: 16531131 [PubMed - indexed for MEDLINE]Related articles

    6.

    beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice.

    Bouxsein ML, Pierroz DD, Glatt V, Goddard DS, Cavat F, Rizzoli R, Ferrari SL.

    J Bone Miner Res. 2005 Apr;20(4):635-43. Epub 2004 Dec 6.PMID: 15765183 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2.

    Ferrari SL, Pierroz DD, Glatt V, Goddard DS, Bianchi EN, Lin FT, Manen D, Bouxsein ML.

    Endocrinology. 2005 Apr;146(4):1854-62. Epub 2005 Feb 10.PMID: 15705780 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Agonist-specific regulation of parathyroid hormone (PTH) receptor type 2 activity: structural and functional analysis of PTH- and tuberoinfundibular peptide (TIP) 39-stimulated desensitization and internalization.

    Bisello A, Manen D, Pierroz DD, Usdin TB, Rizzoli R, Ferrari SL.

    Mol Endocrinol. 2004 Jun;18(6):1486-98. Epub 2004 Feb 26.PMID: 14988434 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity.

    Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS.

    Diabetes. 2002 May;51(5):1337-45.PMID: 11978628 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity.

    Hileman SM, Pierroz DD, Masuzaki H, Bjørbaek C, El-Haschimi K, Banks WA, Flier JS.

    Endocrinology. 2002 Mar;143(3):775-83.PMID: 11861497 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism.

    Raposinho PD, Pierroz DD, Broqua P, White RB, Pedrazzini T, Aubert ML.

    Mol Cell Endocrinol. 2001 Dec 20;185(1-2):195-204.PMID: 11738809 [PubMed - indexed for MEDLINE]Related articles

    12.

    Divergent roles of SHP-2 in ERK activation by leptin receptors.

    Bjørbaek C, Buchholz RM, Davis SM, Bates SH, Pierroz DD, Gu H, Neel BG, Myers MG Jr, Flier JS.

    J Biol Chem. 2001 Feb 16;276(7):4747-55. Epub 2000 Nov 20.PMID: 11085989 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin.

    Kim YB, Uotani S, Pierroz DD, Flier JS, Kahn BB.

    Endocrinology. 2000 Jul;141(7):2328-39.PMID: 10875232 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity.

    El-Haschimi K, Pierroz DD, Hileman SM, Bjørbaek C, Flier JS.

    J Clin Invest. 2000 Jun;105(12):1827-32.PMID: 10862798 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Leptin, nutrition, and reproduction: timing is everything.

    Hileman SM, Pierroz DD, Flier JS.

    J Clin Endocrinol Metab. 2000 Feb;85(2):804-7. Review. No abstract available. PMID: 10690894 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.

    Raposinho PD, Broqua P, Pierroz DD, Hayward A, Dumont Y, Quirion R, Junien JL, Aubert ML.

    Endocrinology. 1999 Sep;140(9):4046-55.PMID: 10465275 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Many LH peaks are needed to physiologically stimulate testosterone secretion: modulation by fasting and NPY.

    Pierroz DD, Aebi AC, Huhtaniemi IT, Aubert ML.

    Am J Physiol. 1999 Apr;276(4 Pt 1):E603-10.PMID: 10198294 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Recombinant forms of rat and human luteinizing hormone and follicle-stimulating hormone; comparison of functions in vitro and in vivo.

    Hakola K, Haavisto AM, Pierroz DD, Aebi A, Rannikko A, Kirjavainen T, Aubert ML, Huhtaniemi I.

    J Endocrinol. 1998 Sep;158(3):441-8.PMID: 9846174 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Chronic administration of leptin into the lateral ventricle induces sexual maturation in severely food-restricted female rats.

    Gruaz NM, Lalaoui M, Pierroz DD, Englaro P, Sizonenko PC, Blum WF, Aubert ML.

    J Neuroendocrinol. 1998 Aug;10(8):627-33.PMID: 9725715 [PubMed - indexed for MEDLINE]Related articles

    20.

    Metabolic control of sexual function and growth: role of neuropeptide Y and leptin.

    Aubert ML, Pierroz DD, Gruaz NM, d'Allèves V, Vuagnat BA, Pralong FP, Blum WF, Sizonenko PC.

    Mol Cell Endocrinol. 1998 May 25;140(1-2):107-13. Review.PMID: 9722177 [PubMed - indexed for MEDLINE]Related articles

    21.

    Dose and time relationships of intravenously injected rat recombinant luteinizing hormone and testicular testosterone secretion in the male Rat.

    Hakola K, Pierroz DD, Aebi A, Vuagnat BA, Aubert ML, Huhtaniemi I.

    Biol Reprod. 1998 Aug;59(2):338-43.PMID: 9687305 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Evidence for a leptin-neuropeptide Y axis for the regulation of growth hormone secretion in the rat.

    Vuagnat BA, Pierroz DD, Lalaoui M, Englaro P, Pralong FP, Blum WF, Aubert ML.

    Neuroendocrinology. 1998 May;67(5):291-300.PMID: 9641610 [PubMed - indexed for MEDLINE]Related articles

    23.

    Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats.

    Pierroz DD, Catzeflis C, Aebi AC, Rivier JE, Aubert ML.

    Endocrinology. 1996 Jan;137(1):3-12.PMID: 8536627 [PubMed - indexed for MEDLINE]Related articles

    24.

    Chronic administration of neuropeptide Y into the lateral ventricle starting at 30 days of life delays sexual maturation in the female rat.

    Pierroz DD, Gruaz NM, d'Alièves V, Aubert ML.

    Neuroendocrinology. 1995 Mar;61(3):293-300.PMID: 7898634 [PubMed - indexed for MEDLINE]Related articles

    25.

    Evidence that neuropeptide Y could represent a neuroendocrine inhibitor of sexual maturation in unfavorable metabolic conditions in the rat.

    Gruaz NM, Pierroz DD, Rohner-Jeanrenaud F, Sizonenko PC, Aubert ML.

    Endocrinology. 1993 Oct;133(4):1891-4.PMID: 8404631 [PubMed - indexed for MEDLINE]Related articles

    26.

    Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats.

    Catzeflis C, Pierroz DD, Rohner-Jeanrenaud F, Rivier JE, Sizonenko PC, Aubert ML.

    Endocrinology. 1993 Jan;132(1):224-34.PMID: 8380374 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    2 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity